South Asian Melioidosis Congress 2017
2017 年南亚类鼻疽大会
基本信息
- 批准号:9398260
- 负责人:
- 金额:$ 0.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-08-10 至 2018-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAreaAsiaAwarenessBacteriaBurkholderia pseudomalleiCase Fatality RatesClinicalClinical MicrobiologyCollaborationsCommunicable DiseasesCommunitiesCongressesCountryDengueDiabetes MellitusDiagnosisDiagnosticDiseaseEmerging Communicable DiseasesEuropeanFundingGram-Negative BacteriaHabitatsHealth PersonnelHumanIndiaIndividualKnowledgeLaboratoriesLeptospirosisMalariaMelioidosisPopulationPopulations at RiskPreventionPublic HealthResearchResearch PersonnelRiskRisk FactorsScheduleSecureSouth AsianSri LankaStudentsTherapeuticTravelTuberculosisUrsidae Familyburden of illnessclinical practicehuman mortalityinterestmeetingsmortalitypreventsymposium
项目摘要
Proposal Summary
Melioidosis is an emerging infectious disease caused by the Gram-negative bacterium Burkholderia
pseudomallei. Mostly confined to the tropics the bacterium's established habitat reaches around the
globe. The global at risk population is estimated at >3 billion people. Although case numbers are
significantly lower than those of well-known diseases such as tuberculosis, malaria, leptospirosis and
dengue, the global fatality of human melioidosis is substantially higher than that of e.g. dengue and
leptospirosis. Hence, in terms of mortality melioidosis could potentially be one of the main “killer”
diseases of the tropics. There is an increasing interest in melioidosis worldwide, and a growing
realization that awareness, diagnosis, treatment and prevention are a matter of great public health
importance. Perhaps nowhere is the interest higher than in South Asia. This is a region estimated to
bear 44% of the global melioidosis burden, yet awareness of the disease and its bacterial cause remains
very low. There is therefore an urgent and continuing need to bring together subject matter experts,
clinicians, academicians, health care workers, and students to disseminate knowledge, to educate, and
to put into clinical practice our evolving knowledge of melioidosis and its bacterial cause B. pseudomallei.
The specific aim of this application is to secure funds for travel, accommodation and registration to
enable at least 10-12 individuals – mostly trainee level clinical researchers, postdoctoral researchers,
and students - to attend the 2nd South Asian Melioidosis Conference (SAMC2017) that will be held in
Colombo, Sri Lanka, from August 29-30, 2017. The main objectives of SAMC2017 are to bring together
75-100 subject matter experts, clinicians, academicians, students, and health care workers to: 1)
communicate and discuss new findings from academic laboratories and clinical settings; 2) discuss
strategies to put into clinical practice proper diagnostics and therapeutics to control and prevent
melioidosis; and 3) aim to sustain such efforts beyond the conference by developing and/or maintaining
strong collaborations and ways to readily disseminate information in South Asia and beyond. The
lessons learned from the 1st South Asian Melioidosis Conference that was held in 2015 in Manipal, India,
clearly showed that the current needs in South Asia are special and that they cannot be met by any of
the other regularly scheduled melioidosis meetings.
提案摘要
类鼻疽是一种由革兰氏阴性菌伯克霍尔德氏菌引起的新发传染病
假鼻疽菌主要局限于该细菌的栖息地到达的热带地区。
全球高危人群估计超过 30 亿。
明显低于结核病、疟疾、钩端螺旋体病等众所周知的疾病
登革热,人类类鼻疽的全球死亡率远高于登革热和登革热等疾病。
因此,就死亡率而言,类鼻疽可能是主要的“杀手”之一。
全世界对类鼻疽病的关注度与日俱增。
认识到认识、诊断、治疗和预防是重大公共卫生问题
也许没有哪个地区比南亚更受关注。
占全球类鼻疽负担的 44%,但对该疾病及其细菌病因的认识仍然存在
因此,迫切需要将主题专家聚集在一起,
牧师、院士、医护人员和学生传播知识、教育和
将我们对类鼻疽及其细菌病因类鼻疽杆菌的不断发展的知识应用于临床实践。
该申请的具体目的是确保获得旅行、住宿和注册资金
至少支持 10-12 人——主要是见习级临床研究人员、博士后研究人员、
和学生 - 参加第二届南亚类鼻疽会议(SAMC2017),该会议将于
斯里兰卡科伦坡,2017 年 8 月 29 日至 30 日。SAMC2017 的主要目标是将
75-100 名主题专家、信徒、院士、学生和医护人员:1)
交流和讨论学术实验室和临床环境的新发现;2) 讨论
将适当的诊断和治疗应用于临床实践以控制和预防的策略
类鼻疽;和 3) 旨在通过发展和/或维持在会议之后维持此类努力
强有力的合作以及在南亚及其他地区轻松传播信息的方式。
2015 年在印度马尼帕尔举行的第一届南亚类鼻疽会议的经验教训,
清楚地表明南亚当前的需求是特殊的,任何一方都无法满足这些需求。
其他定期安排的类鼻疽会议。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HERBERT P. SCHWEIZER其他文献
HERBERT P. SCHWEIZER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HERBERT P. SCHWEIZER', 18)}}的其他基金
Emerging antibiotic resistance in Gram-negative pathogens
革兰氏阴性病原体中新出现的抗生素耐药性
- 批准号:
9752147 - 财政年份:2019
- 资助金额:
$ 0.38万 - 项目类别:
Emerging antibiotic resistance in Gram-negative pathogens
革兰氏阴性病原体中新出现的抗生素耐药性
- 批准号:
10328513 - 财政年份:2019
- 资助金额:
$ 0.38万 - 项目类别:
Emerging antibiotic resistance in Gram-negative pathogens
革兰氏阴性病原体中新出现的抗生素耐药性
- 批准号:
10083704 - 财政年份:2019
- 资助金额:
$ 0.38万 - 项目类别:
Emerging antibiotic resistance in Gram-negative pathogens
革兰氏阴性病原体中新出现的抗生素耐药性
- 批准号:
10548230 - 财政年份:2019
- 资助金额:
$ 0.38万 - 项目类别:
Mechanisms of Ferritin-iron Acquisition and Burkholderia pseudomallei Infection.
铁蛋白-铁获取和类鼻疽伯克霍尔德氏菌感染的机制。
- 批准号:
9027352 - 财政年份:2013
- 资助金额:
$ 0.38万 - 项目类别:
Mechanisms of Ferritin-iron Acquisition and Burkholderia pseudomallei Infection.
铁蛋白-铁获取和类鼻疽伯克霍尔德氏菌感染的机制。
- 批准号:
8605839 - 财政年份:2013
- 资助金额:
$ 0.38万 - 项目类别:
Mechanisms of Ferritin-iron Acquisition and Burkholderia pseudomallei Infection.
铁蛋白-铁获取和类鼻疽伯克霍尔德氏菌感染的机制。
- 批准号:
8512182 - 财政年份:2013
- 资助金额:
$ 0.38万 - 项目类别:
Burkholderia pseudomallei antimicrobial resistance mechanisms
类鼻疽伯克霍尔德氏菌耐药机制
- 批准号:
8261423 - 财政年份:2011
- 资助金额:
$ 0.38万 - 项目类别:
相似国自然基金
京津冀水供给服务空间流动及其生态阈值对跨区域国土空间的影响与优化
- 批准号:42301344
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
区域医疗一体化对基层医疗机构合理用药的影响及优化策略——基于创新扩散理论
- 批准号:72304011
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
政府数据开放与资本跨区域流动:影响机理与经济后果
- 批准号:72302091
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
农产品出口区域化管理对企业和农户的行为决策及经济绩效影响研究
- 批准号:72373067
- 批准年份:2023
- 资助金额:41 万元
- 项目类别:面上项目
转录因子ISL1基因启动子区域突变影响基因转录调控及其对室间隔缺损发生的作用机制研究
- 批准号:82300340
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Executive functions in urban Hispanic/Latino youth: exposure to mixture of arsenic and pesticides during childhood
城市西班牙裔/拉丁裔青年的执行功能:童年时期接触砷和农药的混合物
- 批准号:
10751106 - 财政年份:2024
- 资助金额:
$ 0.38万 - 项目类别:
Implementation of Innovative Treatment for Moral Injury Syndrome: A Hybrid Type 2 Study
道德伤害综合症创新治疗的实施:2 型混合研究
- 批准号:
10752930 - 财政年份:2024
- 资助金额:
$ 0.38万 - 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 0.38万 - 项目类别:
1/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership
1/2 药物开发和能力建设:UCR/CoH-CCC 合作伙伴关系
- 批准号:
10762157 - 财政年份:2023
- 资助金额:
$ 0.38万 - 项目类别:
Translational genomics in gout: From GWAS signal to mechanism
痛风的转化基因组学:从 GWAS 信号到机制
- 批准号:
10735151 - 财政年份:2023
- 资助金额:
$ 0.38万 - 项目类别: